STAT Plus: Breast cancer drug picked up by AstraZeneca shrinks tumors in majority of women with common tumor
The new drug, trastuzumab deruxtecan, was tested in a clinical trial of 184 breast cancer patients whose tumors tested positive for a marker called HER2.
No hay comentarios:
Publicar un comentario